Biotest AG
BIESF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $124,200 | $203,500 | $150,700 | $156,800 |
| % Growth | -39% | 35% | -3.9% | – |
| Cost of Goods Sold | $110,100 | $150,600 | $121,500 | $105,700 |
| Gross Profit | $14,100 | $52,900 | $29,200 | $51,100 |
| % Margin | 11.4% | 26% | 19.4% | 32.6% |
| R&D Expenses | $15,100 | $10,600 | $17,000 | $14,200 |
| G&A Expenses | $9,800 | $11,100 | $8,900 | $8,300 |
| SG&A Expenses | $20,600 | $28,800 | $14,800 | $21,400 |
| Sales & Mktg Exp. | $10,800 | $17,700 | $5,900 | $13,100 |
| Other Operating Expenses | $1,400 | -$9,900 | $4,700 | -$10,100 |
| Operating Expenses | $37,100 | $29,500 | $36,500 | $25,500 |
| Operating Income | -$23,000 | $23,400 | -$7,300 | $25,600 |
| % Margin | -18.5% | 11.5% | -4.8% | 16.3% |
| Other Income/Exp. Net | -$7,100 | -$21,300 | -$7,600 | -$8,300 |
| Pre-Tax Income | -$30,100 | $2,100 | -$14,900 | $17,300 |
| Tax Expense | -$8,700 | $5,600 | -$5,600 | $7,600 |
| Net Income | -$21,400 | -$3,500 | -$9,300 | $9,700 |
| % Margin | -17.2% | -1.7% | -6.2% | 6.2% |
| EPS | -0.55 | -0.094 | -0.25 | 0.24 |
| % Growth | -485.1% | 62.4% | -204.2% | – |
| EPS Diluted | -0.55 | -0.094 | -0.25 | 0.24 |
| Weighted Avg Shares Out | 38,909 | 37,200 | 37,200 | 40,417 |
| Weighted Avg Shares Out Dil | 38,909 | 37,200 | 37,200 | 40,417 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5,000 | $0 | $1,900 | $1,700 |
| Interest Expense | $12,100 | $1,300 | $9,500 | $10,000 |
| Depreciation & Amortization | $8,475 | $8,475 | $7,600 | $9,250 |
| EBITDA | -$9,525 | $11,775 | $2,200 | $34,850 |
| % Margin | -7.7% | 5.8% | 1.5% | 22.2% |